Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-20

FDA Approved: AZELEX — Supplemental Application (Almirall, LLC)

View source ↗

Summary

FDA supplemental application for AZELEX (azelaic acid) submitted by Almirall, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZELEX (AZELAIC ACID)

Snippet

SUPPL AP for AZELEX (AZELAIC ACID)